Profit expected to be up 30% to $21.1m minimum.
Australian Pharmaceutical Industries Limited (API) has upgraded its net profit after tax forecast to a minimum of $21.1m for first half of the 2015 financial year.
This is up 30% year-on-year, compared with a previous expected increase in net profit after tax of 20 to 25% announced at its annual general meeting (PD 30 Jan).
The upgraded forecast was due to strong trading in January and February in the Priceline and Priceline Pharmacy network, API said.
The final half year results will be released on 23 Apr.
For more, see tomorrow’s Pharmacy Daily.
